934049

GlaxoSmithKline Manufacturing S.p.A. — FEI 3002807114

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 27, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Torrile (Italy)

Citations

IDCFRDescription
104921 CFR 211.22(a)Approve or reject components, products
109821 CFR 211.22(c)Approve or reject procedures or specs
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
145121 CFR 211.113(b)Procedures for sterile drug products
187621 CFR 211.180(b)Record maintenance 1 year (except exempt OTC)
188321 CFR 211.165(a)Testing and release for distribution
203121 CFR 211.194(a)Complete test data included in records
358521 CFR 211.110(a)Control procedures to monitor and validate performance